Recurrent adult lymphoblastic lymphoma Trials in Chicago, United States

Clinical trials for Recurrent adult lymphoblastic lymphoma investigate a range of treatment strategies and patient populations.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT01805037	Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas	TERMINATED	PHASE1/PHASE2
NCT01839916	Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies	COMPLETED	PHASE2
NCT00118170	Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function	COMPLETED	PHASE1
NCT00003970	Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma	COMPLETED	PHASE1
NCT00077155	Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma	COMPLETED	PHASE1
NCT03504644	Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia	ACTIVE_NOT_RECRUITING	PHASE1/PHASE2
NCT00290472	CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia	COMPLETED	PHASE2
NCT01748721	MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma	COMPLETED	PHASE1
NCT00873093	Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	COMPLETED	PHASE2
NCT00890747	Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy	COMPLETED	PHASE1